Search results
Screening recommendations should be adapted based on anatomy, (i.e., annual, routine screening for chlamydia in cisgender women < 25 years old should be extended to all transgender men and gender diverse people with a cervix.
This 2021 Recommendation Statement from the US Preventive Services Task Force recommends that all sexually active women 24 years or younger and women 25 years or older at increased risk for infection be screened for chlamydia (B recommendation) and gonorrhea (B recommendation) and concludes that current evidence is insufficient to assess the ...
- Amy Cantor, Tracy Dana, Jessica C. Griffin, Heidi D. Nelson, Chandler Weeks, Kevin L. Winthrop, Roge...
- 2021
- Findings and Research Gaps
- Family Physician Perspective
- Response to Public Comment
- Other Resources
- Up Next
The task force found convincing evidence that clinicians could identify sexually active women at increased risk for chlamydial and gonococcal infections, but only adequate evidence that clinicians could identify sexually active men at increased risk for the same infections. The USPSTF also found convincing evidence that available screening tests ca...
Shannon Connolly, M.D., of Los Angeles, a member of the Academy’s Commission on Health of the Public and Science, and co-author of an AAFP practice manual on screening for STIs, told AAFP Newsthat the recommendation statement provides a clear directive to FPs to continue screening for chlamydia and gonorrhea. “We must simply do a better job of scre...
A draft version of the recommendation statementwas posted for public comment on the USPSTF website from March 2-29, 2021. Several commenters expressed concern that the task force found insufficient evidence to screen men and did not provide separate recommendations for specific high-risk populations. In response, the task force stated that it did n...
In addition to the final recommendation statement, the task force posted links to several resources on its website. These include: 1. AMA Ed Hub: JN Learning: USPSTF Recommendation: Screening for Chlamydia and Gonorrhea, 2. CDC: STI Treatment Guidelines, 3. JAMAPatient Page: Screening for Chlamydia and Gonorrhea, 4. Morbidity and Mortality Weekly R...
The AAFP’s Commission on Health of the Public and Science plans to review the task force’s final recommendation statement, final evidence summary and evidence review, and will then determine the Academy’s stance on the recommendation, up to and including a revision of the Academy’s current recommendation. Once the review is completed, members can v...
- Michael Devitt
Apr 1, 2015 · The USPSTF recommends screening for chlamydia in sexually active women aged 24 years or younger and in older women who are at increased risk for infection.
Sep 13, 2023 · This rationale underlies the recommendation to screen for gonorrhea and chlamydia more clearly among cisgender women than cisgender men, because cisgender women are at risk for pelvic inflammatory disease and infertility from these infections, whereas clinical sequelae are less common, and generally less morbid, for cisgender men. 3 This ...
Women aged <25 years and those at increased risk for chlamydia (i.e., those who have a new sex partner, more than one sex partner, a sex partner with concurrent partners, or a sex partner who has an STI) should be screened at the first prenatal visit and rescreened during the third trimester to prevent maternal postnatal complications and ...
The US Preventive Services Task Force (USPSTF) concludes with moderate certainty that screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection has moderate net benefit.
